Qube Research & Technologies LTD Siga Technologies Inc Transaction History

Qube Research & Technologies LTD

  • $91.4 Billion
  • Q3 2025

A detailed history of Qube Research & Technologies LTD transactions in Siga Technologies Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 46,189 shares of SIGA stock, worth $280,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,189
Holding current value
$280,829
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$6.46 - $9.48 $298,380 - $437,871
46,189 New
46,189 $422,000
Q2 2024

Aug 14, 2024
BUY
$6.32 - $10.46 $467,029 - $772,962
73,897 Added 120.38%
135,284 $1.03 Million
Q1 2024

May 14, 2024
BUY
$4.51 - $8.92 $65,259 - $129,072
14,470 Added 30.84%
61,387 $525,000
Q4 2023

Feb 13, 2024
SELL
$4.82 - $6.25 $123,936 - $160,706
-25,713 Reduced 35.4%
46,917 $262,000
Q3 2023

Nov 13, 2023
SELL
$4.32 - $5.77 $408,326 - $545,380
-94,520 Reduced 56.55%
72,630 $381,000
Q2 2023

Aug 14, 2023
SELL
$5.0 - $6.31 $488,180 - $616,083
-97,636 Reduced 36.87%
167,150 $844,000
Q1 2023

May 15, 2023
SELL
$5.23 - $8.42 $2.1 Million - $3.39 Million
-402,419 Reduced 60.31%
264,786 $1.52 Million
Q4 2022

Feb 14, 2023
SELL
$7.29 - $10.14 $2.99 Million - $4.16 Million
-410,463 Reduced 38.09%
667,205 $4.91 Million
Q3 2022

Nov 14, 2022
BUY
$10.02 - $26.15 $10.5 Million - $27.4 Million
1,048,721 Added 3622.9%
1,077,668 $11.1 Million
Q2 2022

Aug 15, 2022
BUY
$6.5 - $13.68 $188,155 - $395,994
28,947 New
28,947 $335,000
Q1 2022

May 09, 2022
SELL
$5.96 - $7.61 $64,886 - $82,850
-10,887 Closed
0 $0
Q4 2021

Feb 01, 2022
BUY
$6.96 - $9.26 $75,773 - $100,813
10,887 New
10,887 $82,000

Others Institutions Holding SIGA

# of Institutions
205
Shares Held
35.5M
Call Options Held
70.9K
Put Options Held
16.6K
View Full List

About SIGA TECHNOLOGIES INC

SIGA Quotes by TradingView
  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $444M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email